RDHL News and Press, Redhill Biopharma Ltd. From 03/17/23

2023-03-17 02:19:01 ET RedHill Biopharma ( NASDAQ: RDHL ) plans to change the ADS ratio to its non-traded ordinary shares, from one ADS representing ten ordinary shares to one ADS representing four hundred ordinary shares. For the company ...

RedHill Biopharma Announces Plan to Implement ADS Ratio Change PR Newswire TEL AVIV, Israel and RALEIGH, NC , March 16, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, tod...

RedHill Biopharma Announces Definitive Agreement for Up To $6 Million Private Placement with a Single Investor PR Newswire TEL AVIV, Israel and RALEIGH, NC , March 8, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Compan...

RedHill's Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program The National Institutes of Health's (NIH) Radiation and Nuclear Countermeasures Program (RNCP) has selected opaganib for testing via their radiation medical countermeasures Product Development Support contr...

RedHill's Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program PR Newswire The National Institutes of Health's (NIH) Radiation and Nuclear Countermeasures Program (RNCP) has selected opaganib for testing via their radiation medical countermeasures Product...

RedHill Announces Positive MHRA Meeting and Planned UK Marketing Authorisation Application of RHB-102 (BEKINDA ® ) for Oncology Support UK MHRA scientific advice meeting deems RHB-102 (BEKINDA ® ) data supportive of submission for approval for chemotherapy and radiotherapy induced ...

RedHill Announces Positive MHRA Meeting and Planned UK Marketing Authorisation Application of RHB-102 (BEKINDA®) for Oncology Support PR Newswire UK MHRA scientific advice meeting deems RHB-102 (BEKINDA ® ) data supportive of submission for approval for...

RedHill Biopharma Announces Positive FDA Meeting Regarding Opaganib for Acute Nuclear Radiation Syndrome PR Newswire FDA provided guidance on opaganib's regulatory pathway under the Animal Rule for Acute Radiation Syndrome (ARS) The FDA's Animal Rule allows...

RedHill Biopharma and HealthCare Royalty Agree to Extinguish All RedHill's Debt Obligations in Exchange for Movantik® PR Newswire TEL AVIV, Israel and RALEIGH, N.C , Feb. 6, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or...

3 Ways That Market Trends Impact Penny Stocks Performance Market trends can have a significant impact on the performance of penny stocks. Understanding these trends can help investors identify opportunities and make informed investment decisions. One way that market trends can impact pe...